Researchers look at benefits of flu vaccines in the elderly

October 17, 2013 by Sarah Craig

New research at the University of Notre Dame looks more closely at the effects of the influenza vaccine on the elderly, who are considered the highest-risk group for influenza-related mortality.

Despite the fact that the elderly are more susceptible to falling ill, very little is known about how well the performs for those older than 65 years of age. The new study, which looks at the effects of the influenza vaccine in Canada, is the largest to date in terms of numbers of individuals studied and duration. Seniors "age 65 and older are among those at highest risk of serious outcomes following ," said lead author Benjamin Ridenhour, assistant professor of biological sciences and a member of the Eck Institute for Global Health at Notre Dame, in a manuscript being published this week. While annual flu vaccines are recommended for the older population in the United States, Canada and many other developed countries, debate remains on the effectiveness of the vaccines for this older at-risk group.

The study, published in PLOS ONE, titled, "Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: Estimates with generalized linear models accounting for healthy vaccinee effects," questions the effectiveness of influenza vaccines in older adults. The researchers' findings indicate that previous estimates of influenza may be upwardly biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. The authors said, "We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications."

In their central findings of the research, the authors said, "By combining health data with climate data and developing novel statistical analyses, we found that vaccination was 19 percent effective at preventing pneumonia- or influenza-related hospitalizations and 25 percent effective at preventing death occurring subsequent to a pneumonia- or influenza-related hospitalization."

The results indicate that, over a long time period, the influenza vaccine has performed worse than expected in elderly individuals, thus proving the need for improvements in influenza vaccine development.

Annually, influenza kills approximately 25,000 people in the United States, according to the Centers for Disease Control and Prevention. Likewise, the World Health Organization estimates that nearly 500,000 deaths per year occur globally due to .

Ridenhour specializes in the evolution and ecology of infectious diseases. His research focuses on understanding their spatial and temporal dynamics with particular interest in understanding disease transmission to reduce global burden.

Explore further: CDC: 2012-2013 flu vaccine not as effective in elderly

Related Stories

CDC: 2012-2013 flu vaccine not as effective in elderly

February 25, 2013

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research ...

New moms and obese people risk complications from influenza

August 27, 2013

Although up to 500,000 people world-wide die of severe influenza each year, there has been no clear evidence about who is susceptible for influenza complications and it may not be who people think, says a study from McMaster ...

Kids with neuro disorders no more likely to get flu vaccine

September 16, 2013

(HealthDay)—Although children with neurologic conditions are at high risk for complications of influenza infection, only half were vaccinated during the 2011 to 2012 influenza season, according to a report published in ...

CDC: Flu activity still up in U.S. in fourth week of 2013

February 4, 2013

(HealthDay)—In the fourth week of 2013, influenza activity remained elevated in the United States, with the proportion of pneumonia and influenza-linked deaths above the epidemic threshold, according to FluView, a weekly ...

Recommended for you

Zika in fetal brain tissue responds to a popular antibiotic

November 30, 2016

Working in the lab, UC San Francisco researchers have identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin, a common antibiotic regarded as safe for use during pregnancy, ...

Zika and glaucoma linked for first time in new study

November 30, 2016

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Flu forecasts successful on neighborhood level

November 30, 2016

Scientists at Columbia University's Mailman School of Public Health developed a computer model to predict the onset, duration, and magnitude of influenza outbreaks for New York City boroughs and neighborhoods. They found ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.